EGFR and adenocarcinoma: The clinical characteristics of patients with EGFR e20ins are similar to those with EGFR classic mutations, which are more prevalent in females, nonsmokers, and tumors with adenocarcinoma histology (Oxnard et al., 2013; Riess et al., 2018).